Read + Share
Amedeo Smart
Independent Medical Education
Mahase E. Covid-19: Russian vaccine efficacy is 91.6%, show phase III trial results. BMJ 2021;372:n309.PMID: 33531342
Email
LinkedIn
Facebook
Twitter
Privacy Policy